Urologie
Managementul şi optimizarea hemostazei
Agenți antifibrinolitici
Intraoperative use of tranexamic acid to reduce transfusion rate in patients undergoing radical retropubic prostatectomy: double blind, randomised, placebo controlled trial. (se deschide o fereastră nouă)
Sursă: BMJ 2011;343:d5701.
Index: PubMed 22012809
https://www.ncbi.nlm.nih.gov/pubmed/22012809 (se deschide o fereastră nouă)
Tranexamic acid in patients undergoing noncardiac surgery. (se deschide o fereastră nouă)
Sursă: N Engl J Med. 2022;386(21):1986-97.
Index: PubMed 35363452
DOI: 10.1056/NEJMoa2201171
https://pubmed.ncbi.nlm.nih.gov/35363452/ (se deschide o fereastră nouă)
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. (se deschide o fereastră nouă)
Sursă: Cochrane Database Syst Rev 2011;(3):CD001886.
Index: PubMed 21412876
DOI: 10.1002/14651858.CD001886.pub4
https://www.ncbi.nlm.nih.gov/pubmed/21412876 (se deschide o fereastră nouă)
Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. (se deschide o fereastră nouă)
Sursă: BMJ 2012;344:e3054.
Index: PubMed 22611164
https://www.ncbi.nlm.nih.gov/pubmed/22611164 (se deschide o fereastră nouă)
Tranexamic acid reduces blood loss during percutaneous nephrolithotomy: a prospective randomized controlled study. (se deschide o fereastră nouă)
Sursă: J Urol 2013;189(5):1757-61.
Index: PubMed 23123376
DOI: 10.1016/j.juro.2012.10.115
https://www.ncbi.nlm.nih.gov/pubmed/23123376 (se deschide o fereastră nouă)
Factorul VII (rFVIIa) recombinant activat
Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data. (se deschide o fereastră nouă)
Sursă: Crit Care 2008;12(1):R14.
Index: PubMed 18279513
DOI: 10.1186/cc6788
https://www.ncbi.nlm.nih.gov/pubmed/18279513 (se deschide o fereastră nouă)